3D printing is quite possibly the next greatest chapter in the industrial revolution, and the technology is moving rapidly. Reed Smith’s Life Sciences Health Industry Group recently launched its first 3D printing publication white paper – 3D Printing of Medical Devices: When a Novel Technology Meets Traditional Legal Principles. This paper explores unchartered legal issues arising out of one of the hottest product trends: the use of 3D printing to manufacture medical devices. Much interest surrounds this topic given the rapid rise in 3D manufacturing of all kinds of products – ranging from household goods, guns, medical devices and even cars. Just recently, the FDA even approved the first ever 3D printed drug tablet.
In addition to providing an overview of a wide range of developing legal issues, the paper also includes sections on:
- Regulatory Issues
- Intellectual Property
- Tort Liability
- Environmental Effects and Health Risks in the Work Place
- Insurance Issues
3D printing technology has the potential to radically transform the way medical devices are used to treat patients and save lives, a potential that is already beginning to be felt. One can foresee numerous potential benefits to patients as this technological trend continues – but at the same time, unknown risks and consequences exist. As the legal environment surrounding 3D technology evolves, as well as the technology itself, this white paper will be updated to offer a comprehensive, up-to-date resource.
To read the full 3D printing white paper, click here.